Finally, a combined panel of four common proteins namely haptoglobin, kininogen 1, transferrin and apolipoprotein A1 along with albumin (an established biomarker for MM) were validated in a fresh cohort of serum samples and could be better and minimally invasive diagnostic, prognostic markers for MM. This evidence concerns the gene ALB and Miyoshi myopathy.